Physician profile
Michael D Simanovsky
NPI 1578579561
$16,270.02
in general payments reported to CMS, 2019-2025
67 companies · $3,104 in 2025
The $3,104 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,771 · 2020: $1,283 · 2021: $2,506 · 2022: $2,167 · 2023: $2,683 · 2024: $2,757 · 2025: $3,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,529 · Education: $14.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,529.37 |
| Education | $14.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,894.85 | 2019-2025 | Vraylar, Ubrelvy, Linzess |
| Astrazeneca Pharmaceuticals Lp | $1,576.91 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $1,544.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,285.15 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,065.34 | 2019-2025 | Evenity, Otezla, Repatha |
| Abbott Laboratories | $1,036.70 | 2019-2025 | Freestyle Libre 3, Proclaim, Eterna |
| Pfizer INC. | $791.53 | 2019-2025 | |
| Glaxosmithkline, LLC. | $546.11 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Viiv Healthcare Company | $514.54 | 2022-2025 | Apretude |
| Merck Sharp & Dohme LLC | $511.81 | 2019-2025 | Belsomra, Steglatro, Capvaxive |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $428.03 | 2019-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $378.24 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amarin Pharma, INC. | $353.55 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $307.69 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $304.73 | 2021-2025 |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $257.35 | 2022-2025 | Veozah, Myrbetriq |
| Kowa Pharmaceuticals America, INC. | $203.27 | 2019-2025 | Zoryve |
| Mylan Specialty L.P. | $199.10 | 2020-2024 | Yupelri |
| Sumitomo Pharma America, INC. | $184.76 | 2023-2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $174.44 | 2019-2025 | |
| Eisai INC. | $169.79 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $167.81 | 2019-2024 | Xarelto, Spravato |
| Medtronic, INC. | $139.15 | 2025 | Pulseselect, Symplicity G3 |
| Boston Scientific Corporation | $136.72 | 2021-2025 | Watchman Flx, Watchman Access System |
| Collegium Pharmaceutical, INC. | $126.05 | 2021-2025 | Jornay Pm, Belbuca, Xtampza |
| Daiichi Sankyo INC. | $118.46 | 2024-2025 | Injectafer |
| Takeda Pharmaceuticals U.S.A., INC. | $117.17 | 2019-2022 | |
| Esperion Therapeutics, INC. | $114.65 | 2020-2025 | Nexletol |
| Phathom Pharmaceuticals, INC. | $104.44 | 2024-2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $104.22 | 2020-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Exact Sciences Corporation | $103.36 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $99.86 | 2019-2025 | Eliquis |
| Radius Health, INC. | $96.75 | 2024-2025 | Tymlos |
| Supernus Pharmaceuticals, INC. | $91.43 | 2022-2023 | Qelbree |
| Biohaven Pharmaceutical Holding Company Ltd. | $89.73 | 2022 | |
| Axsome Therapeutics, INC. | $85.44 | 2023-2025 | Auvelity, Sunosi |
| Alnylam Pharmaceuticals INC. | $64.10 | 2023-2024 | Amvuttra |
| Antares Pharma, INC. | $60.86 | 2019-2024 | Xyosted |
| Protega Pharmaceutials INC | $57.28 | 2024-2025 | Roxybond |
| Sanofi Pasteur INC. | $55.67 | 2019-2023 | |
| Scilex Pharmaceuticals INC. | $50.79 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $49.43 | 2019-2022 | |
| Allergan, INC. | $46.05 | 2020 | |
| Tris Pharma INC | $43.92 | 2023-2025 | Dyanavel Xr |
| Genentech USA, INC. | $39.39 | 2019-2022 | |
| Corcept Therapeutics | $33.68 | 2025 | Korlym |
| Gilead Sciences, INC. | $26.74 | 2025 | Yeztugo |
| Nevro Corp. | $23.97 | 2022 | |
| Siemens Medical Solutions USA, INC. | $22.08 | 2023 | Embozene |
| Vertex Pharmaceuticals Incorporated | $20.86 | 2024 | |
| Neurelis, INC. | $20.80 | 2023 | Valtoco |
| Shield Therapeutics INC | $19.22 | 2025 | |
| Mannkind Corporation | $18.48 | 2022 | |
| Optos, INC. | $18.25 | 2021 | |
| Horizon Therapeutics Plc | $17.45 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.55 | 2021 | |
| Electromed, INC. | $15.50 | 2024 | Smartvest |
| Adlon Therapeutics L.P. | $15.19 | 2020 | |
| Melinta Therapeutics, LLC | $14.35 | 2019 | |
| Aytu Biopharma, INC. | $13.94 | 2019 | |
| Idorsia Pharmaceuticals US INC | $13.62 | 2024 | Quviviq |
| Clarus Therapeutics INC. | $13.46 | 2021 | |
| Ironwood Pharmaceuticals, INC | $13.29 | 2023 | Linzess |
| Endo Pharmaceuticals INC. | $12.59 | 2020 | |
| Vertiflex, INC. | $11.41 | 2019 | |
| Circassia INC. | $10.80 | 2019 | |
| Endogastric Solutions, INC | $7.46 | 2023 | Esophyx |
Drugs and devices associated with these payments
Airsupra $704Vraylar $653Apretude $486Ozempic $431Mounjaro $419Freestyle Libre 3 $397Rybelsus $380Breztri $339Jardiance $312Farxiga $312Nurtec Odt $285Wegovy $272Zepbound $269Ubrelvy $266Veozah $211Eliquis $207Trelegy Ellipta $193Kerendia $192Gemtesa $185Xifaxan $169Zavzpret $167Repatha $164Otezla $164Evenity $143Zoryve $134Prevnar 20 $132Comirnaty $132Abrysvo $132Belsomra $131Bevespi Aerosphere $125Injectafer $118Linzess $116Qulipta $115Synjardy $109Pulseselect $108Proclaim $107Voquezna $104Yupelri $99.10Tymlos $96.75Tradjenta $92.41Leqembi $91.06Prolia $87.54Steglatro $81.87Emgality $78.16Cologuard Collection Kit $72.92Leqvio $71.75Xarelto $67.32Krystexxa $66.77Amvuttra $64.10Arexvy $63.38Shingrix $63.38Auvelity $59.07Roxybond $57.28Eterna $56.53Viberzi $49.76Dyanavel Xr $43.92Watchman Flx $40.78Nexletol $40.44Creon $36.83Jornay Pm $36.42Fluzone Quadrivalent Northern Hemisphere $36.20Capvaxive $34.79Austedo Xr $34.46Korlym $33.68Gardasil 9 $32.46Uzedy $31.76Symplicity G3 $30.71The Cologuard Plus Collection Kit $30.44Paxlovid $29.41Synthroid $28.56Saxenda $28.48Bexsero $26.99Yeztugo $26.74Sunosi $26.37Octrode $22.98Embozene $22.08Belbuca $21.58Valtoco $20.80Tzield $20.65Lagevrio $20.24Accrufer $19.22Fluzone High-Dose $18.10Flublok Quadrivalent Northern Hemisphere $18.10Vaqta $17.91Vaxelis $17.91Pneumovax 23 $17.91Vaxneuvance $17.91Xyosted $17.79Watchman Access System $17.36Trulicity $17.20Qelbree $15.54Smartvest $15.50Xtampza $14.54Myrbetriq $14.45Fasenra $13.68Quviviq $13.62Austedo $13.14Spravato $12.74Steglujan $11.09Esophyx $7.46
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Simanovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.